Physician profile
Edward P Conrad
NPI 1750507133
$2,157.09
in general payments reported to CMS, 2019-2025
17 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $886 · 2020: $118 · 2021: $161 · 2022: $335 · 2023: $111 · 2024: $187 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.17 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.96 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $319.30 | 2019-2025 | |
| Janssen Biotech, INC. | $300.52 | 2019-2021 | |
| Genzyme Corporation | $261.89 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $249.99 | 2019 | |
| Janssen Scientific Affairs, LLC | $113.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Ucb, INC. | $56.75 | 2019 | |
| Fresenius Kabi USA, LLC | $50.04 | 2023 | Idacio |
| Leo Pharma INC. | $49.30 | 2021-2022 | |
| Pfizer INC. | $30.19 | 2023 | |
| Lilly USA, LLC | $29.72 | 2022 | |
| Revance Therapeutics, INC. | $28.25 | 2025 | Daxxify |
| Dermavant Sciences, INC. | $25.89 | 2024 | Vtama |
| Organon LLC | $25.74 | 2025 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.51 | 2019 | |
| Amgen INC. | $15.81 | 2025 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.